4.4 Article

LRRK2 P755L variant in sporadic Parkinson's disease

期刊

JOURNAL OF HUMAN GENETICS
卷 53, 期 11-12, 页码 1012-1015

出版社

NATURE PUBLISHING GROUP
DOI: 10.1007/s10038-008-0336-5

关键词

Parkinson's disease; Genetics; PARK8; Leucine-rich repeat kinase 2 (LRRK2); Polymorphism; Association study; Japanese; Ethnic background

资金

  1. Core Research for Evolutional Science and Technology (CREST) of the Japan Science and Technology Agency (JST)
  2. Research Committee of CNS Degenerative Diseases
  3. Ministry of Health, Labor, and Welfare of Japan

向作者/读者索取更多资源

Parkinson's disease (PD) is a neurodegenerative disorder of unknown etiology with probable involvement of genetic-environmental factors. The majority of PD cases ( approximately 90-95%) are sporadic, while familial cases account for approximately 5-10% of PD. In a recent report, a heterozygous LRRK2 P755L mutation within LRRK2 exon 19 was found in 2% of Chinese sporadic PD patients and in 0% of normal controls or Caucasians, suggesting that the mutation is disease-associated with ethnic specificity. To further evaluate the role of LRRK2 P755L variant in sporadic PD, we performed direct sequencing of LRRK2 exon 19 in 501 Japanese sporadic PD patients ( male 249, female 252, aged 28-92 years, mean 65.0 years) and 583 controls of the Japanese general population as an extended association study. In this group, we found six patients (6/501 = 1.2%) and eight controls of the general population (8/583 = 1.6%) with a heterozygous P755L variant (P = 0.80, chi(2) = 0.064). No other variants were found in exon 19. Together with previous reports, our extended case-controlled study of large sample size suggests that LRRK2 P755L is a non-disease-associated polymorphism in PD patients.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Multidisciplinary Sciences

Effects of rasagiline on Parkinson's Disease Questionnaire (PDQ-39) emotional well-being domain in patients with Parkinson's disease: A post-hoc analysis of clinical trials in Japan

Nobutaka Hattori, Atsushi Takeda, Yuki Hanya, Tadayuki Kitagawa, Masaki Arai, Yoshihiko Furusawa, Hideki Mochizuki, Masahiro Nagai, Ryosuke Takahashi

Summary: This study investigated the mechanism of how rasagiline affects the emotional well-being domain of PDQ-39 in Japanese patients with Parkinson's disease. The results showed that the effects of rasagiline on the emotional well-being domain were primarily mediated by its influence on the subjective aspects of motor experiences of daily living.

PLOS ONE (2022)

Letter Clinical Neurology

Deep Brain Stimulation for a Patient with Familial Parkinson's Disease Harboring CHCHD2 p.T61I

Hikaru Kamo, Genko Oyama, Kenya Nishioka, Manabu Funayama, Nobutaka Hattori

MOVEMENT DISORDERS CLINICAL PRACTICE (2022)

Review Genetics & Heredity

Molecular genetics of Parkinson's disease: Contributions and global trends

Manabu Funayama, Kenya Nishioka, Yuanzhe Li, Nobutaka Hattori

Summary: Parkinson's disease is a neurodegenerative disorder primarily characterized by motor dysfunction. Genetic factors, in addition to aging and environmental factors, play an important role in the development of the disorder. Familial PD has identified approximately 20 causative genes, while sporadic PD has over 200 potential driver genes.

JOURNAL OF HUMAN GENETICS (2023)

Article Genetics & Heredity

Analysis of LIN28A variants in patients with Parkinson's disease

Hao Peng, Yuanzhe Li, Hiroyo Yoshino, Mai Shimizu, Kenya Nishioka, Manabu Funayama, Nobutaka Hattori

Summary: A recent study reported that a heterozygous loss-of-function variant in LIN28A was a novel pathogenic gene in PD patients from Korea. However, this study aimed to determine the prevalence of LIN28A variants among Japanese PD patients and found no strong association between LIN28A and early-onset PD in this population.

JOURNAL OF HUMAN GENETICS (2023)

Article Clinical Neurology

Embracing Monogenic Parkinson's Disease: The MJFF Global Genetic PD Cohort

Eva-Juliane Vollstedt, Susen Schaake, Katja Lohmann, Shalini Padmanabhan, Alexis Brice, Suzanne Lesage, Christelle Tesson, Marie Vidailhet, Isabel Wurster, Faycel Hentati, Anat Mirelman, Nir Giladi, Karen Marder, Cheryl Waters, Stanley Fahn, Meike Kasten, Norbert Bruggemann, Max Borsche, Tatiana Foroud, Eduardo Tolosa, Alicia Garrido, Grazia Annesi, Monica Gagliardi, Maria Bozi, Leonidas Stefanis, Joaquim J. Ferreira, Leonor Correia Guedes, Micol Avenali, Simona Petrucci, Lorraine Clark, Ekaterina Y. Fedotova, Natalya Y. Abramycheva, Victoria Alvarez, Manuel Menendez-Gonzalez, Silvia Jesus Maestre, Pilar Gomez-Garre, Pablo Mir, Andrea Carmine Belin, Caroline Ran, Chin-Hsien Lin, Ming-Che Kuo, David Crosiers, Zbigniew K. Wszolek, Owen A. Ross, Joseph Jankovic, Kenya Nishioka, Manabu Funayama, Jordi Clarimon, Caroline H. Williams-Gray, Marta Camacho, Mario Cornejo-Olivas, Luis Torres-Ramirez, Yih-Ru Wu, Guey-Jen Lee-Chen, Ana Morgadinho, Teeratorn Pulkes, Pichet Termsarasab, Daniela Berg, Gregor Kuhlenbaumer, Andrea A. Kuhn, Friederike Borngraeber, Giuseppe de Michele, Anna De Rosa, Alexander Zimprich, Andreas Puschmann, George D. Mellick, Jolanta Dorszewska, Jonathan Carr, Rosangela Ferese, Stefano Gambardella, Bruce Chase, Katerina Markopoulou, Wataru Satake, Tatsushi Toda, Malco Rossi, Marcelo Merello, Timothy Lynch, Diana A. Olszewska, Shen-Yang Lim, Azlina Ahmad-Annuar, Ai Huey Tan, Bashayer Al-Mubarak, Hasmet Hanagasi, Dariusz Koziorowski, Sibel Ertan, Gencer Genc, Patricia de Carvalho Aguiar, Melinda Barkhuizen, Marcia M. G. Pimentel, Rachel Saunders-Pullman, Bart van de Warrenburg, Susan Bressman, Mathias Toft, Silke Appel-Cresswell, Anthony E. Lang, Matej Skorvanek, Agnita J. W. Boon, Rejko Kruger, Esther M. Sammler, Vitor Tumas, Bao-Rong Zhang, Gaetan Garraux, Sun Ju Chung, Yun Joong Kim, Juliane Winkelmann, Carolyn M. Sue, Eng-King Tan, Joana Damasio, Peter Klivenyi, Vladimir S. Kostic, David Arkadir, Mika Martikainen, Vanderci Borges, Jens Michael Hertz, Laura Brighina, Mariana Spitz, Oksana Suchowersky, Olaf Riess, Parimal Das, Brit Mollenhauer, Emilia M. Gatto, Maria Skaalum Petersen, Nobutaka Hattori, Ruey-Meei Wu, Sergey N. Illarioshkin, Enza Maria Valente, Jan O. Aasly, Anna Aasly, Roy N. Alcalay, Avner Thaler, Matthew J. Farrer, Kathrin Brockmann, Jean-Christophe Corvol, Christine Klein

Summary: Through a worldwide online survey, we established an international cohort of individuals with PD-linked variants, providing harmonized and quality-controlled clinical and genetic data for each participant and promoting collaboration among researchers in the field of monogenic PD.

MOVEMENT DISORDERS (2023)

Review Biochemistry & Molecular Biology

Is Glial Dysfunction the Key Pathogenesis of LRRK2-Linked Parkinson's Disease?

Tatou Iseki, Yuzuru Imai, Nobutaka Hattori

Summary: Leucine rich-repeat kinase 2 (LRRK2) is the most well-known genetic cause of familial Parkinson's disease (PD). Its functions and relationship to the pathogenesis of PD are not fully understood. Recent studies have suggested that LRRK2 plays a role in glial cell dysfunction and neurodegeneration, particularly in lysosomal dynamics and inflammation. This review discusses the proposed functions of LRRK2 in glial cells and its involvement in the pathomechanisms of PD.

BIOMOLECULES (2023)

Article Biochemistry & Molecular Biology

Propagative α-synuclein seeds as serum biomarkers for synucleinopathies

Ayami Okuzumi, Taku Hatano, Gen Matsumoto, Shuko Nojiri, Shin-ichi Ueno, Yoko Imamichi-Tatano, Haruka Kimura, Soichiro Kakuta, Akihide Kondo, Takeshi Fukuhara, Yuanzhe Li, Manabu Funayama, Shinji Saiki, Daisuke Taniguchi, Taiji Tsunemi, Deborah McIntyre, Jean-Jacques Gerardy, Michel Mittelbronn, Rejko Kruger, Yasuo Uchiyama, Nobuyuki Nukina, Nobutaka Hattori

Summary: A modified assay system (IP/RT-QuIC) has been developed to detect pathogenic alpha-synuclein seeds in the serum of individuals with synucleinopathies. The system showed high diagnostic performance for differentiating Parkinson's disease and multiple system atrophy from controls.

NATURE MEDICINE (2023)

Article Medicine, General & Internal

Survey on the Impact of the COVID-19 Pandemic on Patients with Parkinson's Disease and Their Caregivers in Japan

Nobutaka Hattori, Yoshiko Okada, Yayoi Kawata, Yoshihiko Furusawa, Takumi Imai, Hisako Yoshida, Mihoko Ota, Masaki Arai, Ayumi Shintani, Jovelle Fernandez

Summary: This study aimed to investigate the impact of the COVID-19 pandemic on patients with Parkinson's disease and their caregivers in Japan. The results showed that over 40% of patients reduced their frequency of going out, approximately 7-30% experienced worsened symptoms, and caregivers reported increased burden. The findings suggest the importance of providing support to patients and caregivers during infectious disease epidemics to alleviate their burden.

PATIENT PREFERENCE AND ADHERENCE (2023)

Article Biochemistry & Molecular Biology

Evaluation of Human-Induced Pluripotent Stem Cells Derived from a Patient with Schwartz-Jampel Syndrome Revealed Distinct Hyperexcitability in the Skeletal Muscles

Yuri Yamashita, Satoshi Nakada, Kyoko Nakamura, Hidetoshi Sakurai, Kinji Ohno, Tomohide Goto, Yo Mabuchi, Chihiro Akazawa, Nobutaka Hattori, Eri Arikawa-Hirasawa

Summary: Schwartz-Jampel syndrome (SJS) is a rare genetic disorder characterized by myotonia. In this study, a cellular model of SJS was created using patient-derived induced pluripotent stem cells, which showed hyper-responsiveness to acetylcholine. These findings confirmed the use of cellular models in studying SJS and evaluating myotonia in clinical cases.

BIOMEDICINES (2023)

Editorial Material Clinical Neurology

Interview with Nobutaka Hattori: a life researching Parkinson's disease pathogenesis

Nobutaka Hattori

NEURODEGENERATIVE DISEASE MANAGEMENT (2023)

Article Clinical Neurology

Long-Read Sequencing Resolves a Complex Structural Variant in PRKN Parkinson's Disease

Kensuke Daida, Manabu Funayama, Kimberley J. Billingsley, Laksh Malik, Abigail Miano-Burkhardt, Hampton L. Leonard, Mary B. Makarious, Hirotaka Iwaki, Jinhui Ding, J. Raphael Gibbs, Mayu Ishiguro, Hiroyo Yoshino, Kotaro Ogaki, Genko Oyama, Kenya Nishioka, Risa Nonaka, Wado Akamatsu, Cornelis Blauwendraat, Nobutaka Hattori

Summary: This study identified a large novel 7 Mb inversion involving PRKN, which is associated with young-onset Parkinson's disease. Long-read sequencing proved to be valuable for detecting complex structural variants in unresolved PD cases. The findings highlight the importance of investigating structural variants in PRKN using advanced sequencing technologies.

MOVEMENT DISORDERS (2023)

Article Clinical Neurology

Fiber-Specific White Matter Alterations in Parkinson's Disease Patients with GBA Gene Mutations

Christina Andica, Koji Kamagata, Wataru Uchida, Yuya Saito, Kaito Takabayashi, Akifumi Hagiwara, Haruka Takeshige-Amano, Taku Hatano, Nobutaka Hattori, Shigeki Aoki

Summary: This study compared the white matter differences between nonmedicated patients with early-stage GBA-PD and iPD using a novel technique, fixel-based analysis. The results showed that patients with GBA-PD had lower white matter density, while patients with iPD had larger white matter fiber bundles. These findings may be related to neurodegenerative diseases, α-synuclein accumulation, and cognitive and motor impairments.

MOVEMENT DISORDERS (2023)

Article Neurosciences

Different pieces of the same puzzle: a multifaceted perspective on the complex biological basis of Parkinson's disease

Amica C. Mueller-Nedebock, Marieke C. J. Dekker, Matthew J. Farrer, Nobutaka Hattori, Shen-Yang Lim, George D. Mellick, Irena Rektorova, Mohamed Salama, Artur F. S. Schuh, A. Jon Stoessl, Carolyn M. Sue, Ai Huey Tan, Rene L. Vidal, Christine Klein, Soraya Bardien

Summary: The biological basis of Parkinson's disease, a neurodegenerative movement disorder, is still unclear despite being discovered over 200 years ago. This article summarizes the viewpoints of PD experts on the different theories regarding its pathobiology.

NPJ PARKINSONS DISEASE (2023)

Article Neurosciences

Comparative efficacy and safety of adjunctive drugs to levodopa for fluctuating Parkinson's disease - network meta-analysis

Wataru Sako, Yuki Kogo, Michinori Koebis, Yoshiaki Kita, Hajime Yamakage, Takayuki Ishida, Nobutaka Hattori

Summary: This study compared the efficacy, tolerability, and safety of different classes of anti-PD drugs in patients with fluctuating PD who were receiving levodopa. The results showed that ropinirole, pramipexole, and safinamide are well-balanced anti-PD drugs that have both good efficacy and tolerability.

NPJ PARKINSONS DISEASE (2023)

Article Biology

Mycobacterium avium subsp. paratuberculosis Antigens Elicit a Strong IgG4 Response in Patients with Multiple Sclerosis and Exacerbate Experimental Autoimmune Encephalomyelitis

Davide Cossu, Yuji Tomizawa, Kazumasa Yokoyama, Tamami Sakanishi, Eiichi Momotani, Leonardo A. Sechi, Nobutaka Hattori

Summary: The study analyzed the levels of different IgG subclasses in the blood of Japanese and Italian individuals with relapsing remitting multiple sclerosis (MS) in response to MAP-derived peptides. The study also examined the effects of MAP peptides on MOG-induced experimental autoimmune encephalomyelitis (EAE) in mice. The results suggest a potential link between MAP and the development or exacerbation of MS, particularly in individuals with elevated serum IgG4 levels.

LIFE-BASEL (2023)

暂无数据